random double-blind placebo-control cross-ov trial side effect medroxyprogesteron acet hormon replac therapi cyclic progestin therapi adjunct estrogen replac therapi risk endometri carcinoma accept approach detail evalu possibl advers side effect progestin patient noncompli nonmenstru physic psycholog side effect oral medroxyprogesteron acet conjunct transderm estrogen group women previou hysterectomi oophorectomi twenty-four women sever premenstru syndrom pm surgeri women histori advers premenstru chang transderm estrogen microgram day oral medroxyprogesteron acet mg ident placebo day random double-blind cross-ov design mood physic symptom daili self-rat daili symptom checklist beck depress inventori premenstru tension self-rat scale day studi complet patient treatment period pair comparison signific differ prefer treatment medroxyprogesteron acet placebo addit medroxyprogesteron acet mg/day day transderm estrogen therapi day consist advers physic psycholog effect women cycl treatment pm histori 